Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) released its earnings results on Wednesday. The company reported $0.19 earnings per share for the quarter, missing the consensus estimate of $0.21 by ($0.02), Zacks reports. The firm had revenue of $321.10 million during the quarter, compared to analyst estimates of $329.85 million.
Guardian Pharmacy Services Price Performance
GRDN traded up $0.40 on Monday, reaching $20.55. 22,483 shares of the company traded hands, compared to its average volume of 157,178. Guardian Pharmacy Services has a one year low of $14.16 and a one year high of $25.74. The firm has a fifty day moving average price of $20.55.
Guardian Pharmacy Services Company Profile
(
Get Free Report)
Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.
Featured Articles
Before you consider Guardian Pharmacy Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Guardian Pharmacy Services wasn't on the list.
While Guardian Pharmacy Services currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
